Stay updated on Palovarotene for MO: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Palovarotene for MO: Efficacy & Safety Clinical Trial page.

Latest updates to the Palovarotene for MO: Efficacy & Safety Clinical Trial page
- Check2 days agoChange DetectedPosted results and updated study-record dates were added to the study record, including references to primary and secondary outcomes.SummaryDifference0.1%

- Check10 days agoChange DetectedThe page now shows Revision: v3.4.2, replacing v3.4.1. This appears to be a minor version update with no changes to core study data, eligibility, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check17 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no changes to study details, locations, or primary content are visible in the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check24 days agoChange DetectedNo significant content changes detected between the two page views; core study details such as design, outcomes, eligibility criteria, and locations appear unchanged, with only minor UI/formatting differences observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check31 days agoChange DetectedAdded a 'Show glossary' option and updated footer labels to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data,' including capitalization adjustments. Updated the revision tag from 'Revision: v3.3.4' to 'Revision: v3.4.0'.SummaryDifference0.2%

- Check38 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. This appears to be a minor maintenance update with no visible impact on study content or functionality.SummaryDifference0.1%

Stay in the know with updates to Palovarotene for MO: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Palovarotene for MO: Efficacy & Safety Clinical Trial page.